The patient, a 19-year-old university student who has asked to remain anonymous, had a sample of testicular tissue removed and cryopreserved in 2023, before he underwent a bone marrow transplant to treat a serious blood disorder. Bone marrow transplantation requires high-dose chemotherapy, a regimen that can permanently destroy the spermatogonial stem cells responsible for sperm production throughout adult life. Three years after completing his treatment, clinical tests confirmed that no sperm were present in his semen, a finding that would previously have left him with no options at all.

In August 2026, surgeons reimplanted small pieces of his preserved tissue in the hope that the stored stem cells would recolonise the testis and resume spermatogenesis, the complex biological process by which sperm cells mature. The young man has recovered well and will now be monitored closely. After eight months, a sample of the transplanted tissue will be surgically removed and examined under the microscope to determine whether sperm have actually been produced. That checkpoint will provide the first concrete evidence of whether the procedure has worked in a UK patient.

The scientific logic behind the approach rests on the biology of the testis itself. Within the seminiferous tubules, spermatogonial stem cells divide and differentiate from puberty onwards, generating the successive generations of cells that ultimately become mature sperm. Chemotherapy agents and radiotherapy are highly toxic to these rapidly dividing lineages, and in prepubertal boys the tissue has not yet begun producing sperm at all. Freezing small fragments of tissue before treatment therefore preserves the only cells capable of restarting sperm production later in life, even though the tissue at the time of storage is biologically immature.

This is precisely why the technique matters for a group that existing medicine cannot serve. Semen cryopreservation is a well-established fertility preservation option for adolescent and adult males, who can simply bank a sperm sample before starting treatment. Prepubertal boys, however, do not yet produce sperm, so there has been no established clinical method to restore their fertility after sterilising therapies. More than 1,200 patients in the UK and around 3,100 worldwide have now had testicular tissue stored for potential future clinical use, creating a growing cohort of young people who may one day return to clinics like the one in Edinburgh hoping to use it.

The Edinburgh testicular project, established in 2015 with funding from the charity Children with Cancer UK, has grown over ten years into a national programme for tissue banking and translational research. In 2024 the charity provided further funding specifically to support the transplantation study that made the August 2026 operation possible. The programme’s design reflects a deliberately cautious, evidence-first strategy: tissue is collected and frozen under rigorous clinical protocols, while the transplantation step is evaluated as a research procedure before it can be offered as routine care.

Crucially, the Edinburgh team did not move into human transplantation without prior animal evidence. Studies in non-human primates demonstrated that testicular tissue frozen before sterilising chemotherapy could be transplanted back successfully, with the grafts producing mature sperm that were subsequently used in assisted reproduction to achieve a live birth. That result provided the proof of principle that cryopreserved immature tissue retains its developmental potential after thawing and reimplantation, and that the resulting sperm can lead to a healthy offspring. The primate work also helped define the surgical and biological parameters, such as graft placement and the time needed for blood vessels to regrow into the transplanted tissue and support maturation of the stem cells.

The first demonstration in a human patient came earlier this year in Belgium, where testicular tissue frozen before puberty was successfully transplanted back and subsequently produced mature sperm. That landmark result confirmed that the animal findings could be translated into people, and it set the stage for the Edinburgh procedure as the second reported worldwide. The Belgian case involved tissue preserved in childhood, while the UK patient had tissue stored as an older adolescent, illustrating that the technique may eventually serve a broad age range of patients whose fertility is threatened by treatment.

Study lead Rod Mitchell, Professor of Developmental Endocrinology at the University of Edinburgh’s Institute for Regeneration and Repair and Consultant Paediatric Endocrinologist at NHS Lothian, described the operation as a major advance. He noted that ten years ago the team began freezing and storing pieces of testicular tissue from boys before they started chemotherapy, and that some of those young men are now returning to explore their fertility options. Tracey Gillies, Medical Director at NHS Lothian, called the procedure a landmark step for young people whose future fertility may be compromised by the treatment they need to overcome serious illness, highlighting the collaboration between NHS clinicians and university researchers as an example of world-leading clinical work.

For the patient himself, the procedure carries a significance that extends beyond the laboratory. In a statement, he said that fertility was something he had struggled with personally for a long time, and that he had slowly begun to accept he might never have children of his own. He described the operation as giving him genuine hope for the future, acknowledging that no one yet knows whether it will work but emphasising that even the possibility means more than he can put into words. He also expressed the hope that taking part in the research will help other young people in the same position one day share that hope. Whether the transplanted tissue produces sperm will become clear at the eight-month examination, and even a positive result would likely still require assisted reproduction rather than natural conception. But the procedure has already established a UK-first clinical pathway, and if the Edinburgh team’s careful decade of groundwork pays off, thousands of stored tissue samples around the world could one day offer the same possibility to survivors of childhood and adolescent illness.

Subject of Research: Transplantation of cryopreserved testicular tissue to restore fertility after sterilising cancer treatment

Article Title: UK first as frozen testicular tissue transplanted to help restore fertility

Article References: UK first as frozen testicular tissue transplanted to help restore fertility. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: testicular tissue transplantation, fertility preservation, spermatogonial stem cells, chemotherapy, cryopreservation, University of Edinburgh, NHS Lothian, pediatric oncology, male infertility, bone marrow transplant, assisted reproduction, clinical trial